Peritoneal dialysis (PD) is an important home-based treatment for kidney failure and
accounts for 11% of all dialysis and 9% of all kidney replacement therapy globally. Although …

Peritoneal dialysis (PD)-associated peritonitis is a serious complication of PD and
prevention and treatment of such is important in reducing patient morbidity and mortality …

Patient involvement in clinical trial design can facilitate the recruitment and retention of
participants as well as potentially increase the uptake of the tested intervention and the …

Peritoneal dialysis (PD) catheter-related infections are important risk factors for catheter loss
and peritonitis. The 2023 updated recommendations have revised and clarified definitions …

Home dialysis modalities (home hemodialysis [HD] and peritoneal dialysis [PD]) are
associated with greater patient autonomy and treatment satisfaction compared with in-center …

Individuals with kidney failure undergoing maintenance dialysis frequently report a high
symptom burden that can interfere with functioning and diminish life satisfaction. Until …

Rationale & Objective Individuals faced with decisions regarding kidney replacement
therapy options need information on how dialysis treatments might affect daily activities and …

Life participation requiring physical activity and physical function is a key patient-reported
outcome for people receiving peritoneal dialysis (PD). Clinician guidance is required from …

Peritoneal dialysis (PD)-related peritonitis is one of the top priorities for care and research
among PD stakeholders. This study summarizes PD peritonitis rates from available …

Results Median time on peritoneal dialysis ranged from 1.7 (interquartile range, 0.8–2.9; the
United Kingdom) to 3.2 (interquartile range, 1.5–6.0; Japan) years and was longer with …